Navigation Links
Genomics of Cardiovascular Disease: Current Clinical Applications
Date:6/5/2008

KEYNOTE SPEAKER - Kari Stefansson, MD, DR. MED, CEO DeCODE Genetics

WASHINGTON, June 5 /PRNewswire-USNewswire/ -- The following media advisory was issued today by The Cheney Cardiovascular Institute:

Date: Thursday, June 12, 2008

Location: The George Washington University Hospital Auditorium

900 23rd Street, NW

Time: Noon - 2:50pm

Noon - 1:00pm Presentation by Dr. Kari Stefansson

Dr. Stefansson is CEO and co-founder of deCODE genetics and a former professor of neurology, neuropathology, and neuroscience at Harvard University.

The deCODE group has identified unique genomic markers for atherosclerosis, atrial fibrillation, and type II diabetes mellitus. As one of the world's leading experts on genomics, Dr. Stefansson will discuss the current clinical applications of cardiovascular personalized medicine. Key to understanding the potential of genomics, Dr. Stefansson will define single nucleotide polymorphisms (SNPs) and their role in genetic diseases. His talk will highlight the breakthroughs in cardiovascular genomics for both clinical cardiologists as well as researchers.

1:15 - 2:50pm Luncheon panel discussion -

Moderated by Timothy McCaffrey, PhD

Stephen B. Liggett, MD

Professor of Medicine and Physiology

Director, Cardiopulmonary Genomics

University of Maryland School of Medicine

Timothy McCaffrey, PhD

Professor of Biochemistry and Director, McCormick Genomics Center, The George Washington University School of Medicine

Gualberto Ruano, MD, PhD

President and CEO, Genomas, Inc.

The Richard B. and Lynne V. Cheney Cardiovascular Institute at The George Washington University was established in 2006 by a generous charitable contribution from Vice President Richard Cheney and his wife Lynne.

The mission of The Richard B. and Lynne V. Cheney Cardiovascular Institute is to promote clinical research, education, patient care and community service with the goal of accelerating the pace of scientific discovery, reducing mortality and improving the quality of life of Americans with cardiovascular disease. To achieve these goals, the Institute seeks to provide an interdisciplinary structure to integrate basic and clinical investigators, clinicians, medical educators, health policy experts and community leaders. For more information, please visit http://www.cheneycardioinstitute.com.


'/>"/>
SOURCE The Cheney Cardiovascular Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Navigenics Proposes Standards for Personal Genomics Services, Coupled With Prospective Outcomes Studies, to Safeguard Consumers
2. Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACCs 57th Annual Scientific Session
3. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
4. NIH announces new initiative in epigenomics
5. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2007 Healthcare Conference
6. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
7. NeoGenomics Announces Results for the 3rd Quarter 2007
8. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
9. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
10. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
11. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: